Delivery Order SPE2DB20D3505-SPE2DB25FT4P2

Award Date 11/18/24
Potential Completion Date 11/19/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,130.03 Firm Fixed Price Delivery Order contract is for the supply of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of October 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,782.20 firm fixed-price delivery order is for the supply of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product, with an ultimate completion date of November 7, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, with ID SPE2DB20D1004|SPE2DB24FF9U2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,555.59, is a delivery order for the supply of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of May 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FZ79F, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,002.29, is a delivery order for the supply of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of December 30, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $51,573.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the procurement of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product. This delivery order does not...
This federal contract award, with ID SPE2DB20D1004|SPE2DB22FG2G2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $23,062.93 firm fixed-price delivery order is for GILENYA 0.5 MG CAPSULE medical supplies, with a completion date of September 26, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as well as a separate $750,000 IDC with...
This federal contract award, SPE2DB22D3016|SPE2DB25FAGS2, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $52,054.33 firm fixed-price delivery order is for the provision of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through December 17, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,566.21 firm fixed-price delivery order is for the supply of GILENYA 0.5 MG CAPSULE 30S, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of November 24, 2023 and does not include any set-aside designations, indicating open competition....
This federal contract award is a Delivery Order with a Firm Fixed Price pricing type, valued at $16,078.45, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of GILENYA 0.5 MG CAPSULE 30S, a specialty medication, with an ultimate completion date of June 26, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has a ceiling value of $35,454.11 and a completion date of March 6, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and this award is part of a larger Indefinite Delivery Contract...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB25FT4P2
    Delivery Order

This federal contract award, SPE2DB20D3505|SPE2DB25FT4P2, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $12,437.36 firm fixed-price delivery order is for the supply of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through November 19, 2024.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated with a set-aside requirement, indicating open competition.

Generated 5/20/25, 2:31 PM